Internal Medicine Journal最新文献

筛选
英文 中文
Clinical perspectives: Takotsubo cardiomyopathy 临床视角:塔克氏心肌病
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-09 DOI: 10.1111/imj.16493
Jayant Ravindran, David Brieger
{"title":"Clinical perspectives: Takotsubo cardiomyopathy","authors":"Jayant Ravindran,&nbsp;David Brieger","doi":"10.1111/imj.16493","DOIUrl":"10.1111/imj.16493","url":null,"abstract":"<p>Takotsubo syndrome is a condition characterised by temporary acute left ventricular dysfunction with regional wall abnormalities extending beyond a single coronary artery territory. Initially thought to be benign, this condition, which is challenging to distinguish from acute coronary syndrome, has substantial morbidity and mortality. The mechanism behind this condition remains elusive, but multiple theories have been proposed. Although beta blockers and angiotensin-converting enzyme inhibitors are used as treatments for left ventricular dysfunction, currently, there are no randomised controlled trials to support their use. In this paper, we review the latest evidence regarding aetiologies, pathophysiology, diagnostic criteria, prognosis, complications and management of Takotsubo syndrome.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 11","pages":"1785-1795"},"PeriodicalIF":1.8,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16493","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global meta-analysis of physicians' experiences of workplace sexual harassment by patients 医生在工作场所遭受患者性骚扰的全球荟萃分析。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-08 DOI: 10.1111/imj.16513
Caroline Kamau-Mitchell, Khalid Bin Waleed, Mark M. Gallagher
{"title":"Global meta-analysis of physicians' experiences of workplace sexual harassment by patients","authors":"Caroline Kamau-Mitchell,&nbsp;Khalid Bin Waleed,&nbsp;Mark M. Gallagher","doi":"10.1111/imj.16513","DOIUrl":"10.1111/imj.16513","url":null,"abstract":"<p>The World Health Organization recognises that sexual harassment is an occupational hazard in medicine, but the prevalence of sexual harassment by patients is unknown. This global meta-analysis found that a pooled prevalence of 45.13% of 18 803 physicians from several specialities (e.g. internal medicine and surgery) have ever experienced it. Hospitals should implement protective measures such as panic alarms for night shifts and isolated wards.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 10","pages":"1760-1764"},"PeriodicalIF":1.8,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16513","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract IMSANZ 2024 会议 2024 年 9 月 4-7 日。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-05 DOI: 10.1111/imj.16486
{"title":"Abstract","authors":"","doi":"10.1111/imj.16486","DOIUrl":"10.1111/imj.16486","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 S3","pages":"4-29"},"PeriodicalIF":1.8,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16486","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy 接受联合疗法的炎症性肠病患者中,6-硫鸟嘌呤核苷酸水平与英夫利西单抗相关,但与阿达木单抗水平无关。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-05 DOI: 10.1111/imj.16504
Natalie Yu, Tanya Lee, Daniel Tassone, Sara Vogrin, Steven Phan, Damien M. Wu, Jason Zhang, Luke Wang, Jason Tjahyadi, Krishneel Dutt, Hana Liou, Chamara Basnayake, Emily Wright, Ola Niewiadomski, Mark Lust, Julien Schulberg, Michael A. Kamm, William Connell, Alexander J. Thompson, Ida Hilmi, Raja A. Raja Ali, Shu C. Wei, Peter De Cruz, Antony B. Friedman, Gregory T. Moore, Daniel Van Langenberg, Nik S. Ding
{"title":"6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy","authors":"Natalie Yu,&nbsp;Tanya Lee,&nbsp;Daniel Tassone,&nbsp;Sara Vogrin,&nbsp;Steven Phan,&nbsp;Damien M. Wu,&nbsp;Jason Zhang,&nbsp;Luke Wang,&nbsp;Jason Tjahyadi,&nbsp;Krishneel Dutt,&nbsp;Hana Liou,&nbsp;Chamara Basnayake,&nbsp;Emily Wright,&nbsp;Ola Niewiadomski,&nbsp;Mark Lust,&nbsp;Julien Schulberg,&nbsp;Michael A. Kamm,&nbsp;William Connell,&nbsp;Alexander J. Thompson,&nbsp;Ida Hilmi,&nbsp;Raja A. Raja Ali,&nbsp;Shu C. Wei,&nbsp;Peter De Cruz,&nbsp;Antony B. Friedman,&nbsp;Gregory T. Moore,&nbsp;Daniel Van Langenberg,&nbsp;Nik S. Ding","doi":"10.1111/imj.16504","DOIUrl":"10.1111/imj.16504","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Thiopurine co-therapy with anti-tumour necrosis factor-alpha (anti-TNFα) agents is associated with higher anti-TNFα drug levels and reduced immunogenicity in inflammatory bowel disease (IBD).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>We aimed to evaluate the association between 6-thioguanine nucleotide (6-TGN) and anti-TNFα levels and the optimal 6-TGN threshold level associated with higher anti-TNFα levels in combination therapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We performed a retrospective cross-sectional multicentre study of patients with IBD on combination anti-TNFα and thiopurine maintenance therapy between January 2015 and August 2021. Primary outcomes were infliximab and adalimumab levels. Secondary outcomes were antibodies to infliximab (ATI) or adalimumab (ATA). Univariable and multivariable linear regression were performed to identify variables associated with anti-TNFα levels. Receiver operator characteristic curves were used to define the optimal 6-TGN cut-off levels associated with therapeutic anti-TNFα levels.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The study included 743 paired 6-TGN and anti-TNFα levels (640 infliximab and 103 adalimumab). 6-TGN levels were associated with infliximab levels, but not adalimumab levels, on univariable and multivariable regression. The optimal 6-TGN cut-off associated with therapeutic infliximab levels (≥5 mcg/mL) was 261 pmol/8 × 10<sup>8</sup> red blood cell (RBC) (area under the curve (AUC) = 0.57) for standard infliximab dosing and 227.5 pmol/8 × 10<sup>8</sup> RBC (AUC = 0.58) for escalated dosing. For therapeutic adalimumab levels (≥7.5 mcg/mL), the 6-TGN cut-off was 218.5 pmol/8 × 10<sup>8</sup> RBC (AUC = 0.59) for standard adalimumab dosing and 237.5 pmol/8 × 10<sup>8</sup> RBC (AUC = 0.63) for escalated dosing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>6-TGN levels were weakly associated with infliximab but not adalimumab levels in combination therapy. 6-TGN levels in the lower end of the therapeutic range (230–260 pmol/8 × 10<sup>8</sup> RBC) may be adequate to maintain higher infliximab levels, particularly with escalated infliximab dosing.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 11","pages":"1856-1866"},"PeriodicalIF":1.8,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of glucose sensors for post-discharge care triaging of insulin-treated patients with type 2 diabetes: a feasibility study 使用血糖传感器对接受过胰岛素治疗的 2 型糖尿病患者进行出院后护理分流:一项可行性研究。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-04 DOI: 10.1111/imj.16494
Ruby Chang, Milan K. Piya, Paige Ara, Brunelle Fernandes, David Simmons
{"title":"Use of glucose sensors for post-discharge care triaging of insulin-treated patients with type 2 diabetes: a feasibility study","authors":"Ruby Chang,&nbsp;Milan K. Piya,&nbsp;Paige Ara,&nbsp;Brunelle Fernandes,&nbsp;David Simmons","doi":"10.1111/imj.16494","DOIUrl":"10.1111/imj.16494","url":null,"abstract":"<p>The use of glucose sensors to triage post-discharge follow-up was investigated among hospital inpatients with type 2 diabetes. Feasibility, utility and patient satisfaction with this model of care were studied. Feasibility was 36.5%, with 90/198 (45.5%) inpatients discharged with glucose sensors but 9.0% unable to use glucose sensors effectively. Follow-up plans were altered in 76.3% of the patients able to use the sensor technology. Patient satisfaction was high and was improved on follow-up after 6 months.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 10","pages":"1739-1743"},"PeriodicalIF":1.8,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16494","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confounding factors in pregnancy outcomes among Indigenous Australian systemic lupus erythematous patients 澳大利亚土著系统性红斑狼疮患者妊娠结局的干扰因素。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-03 DOI: 10.1111/imj.16501
Hasnain Bhurawala
{"title":"Confounding factors in pregnancy outcomes among Indigenous Australian systemic lupus erythematous patients","authors":"Hasnain Bhurawala","doi":"10.1111/imj.16501","DOIUrl":"10.1111/imj.16501","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 9","pages":"1591"},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D status and intermediate vascular and bone outcomes in chronic kidney disease: a secondary post hoc analysis of IMPROVE-CKD 维生素 D 状态与慢性肾脏病的中期血管和骨骼预后:IMPROVE-CKD 的二次事后分析。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-03 DOI: 10.1111/imj.16516
Wing-Chi G. Yeung, Nigel D. Toussaint, Nicole Lioufas, Carmel M. Hawley, Elaine M. Pascoe, Grahame J. Elder, Andrea Valks, Sunil V. Badve
{"title":"Vitamin D status and intermediate vascular and bone outcomes in chronic kidney disease: a secondary post hoc analysis of IMPROVE-CKD","authors":"Wing-Chi G. Yeung,&nbsp;Nigel D. Toussaint,&nbsp;Nicole Lioufas,&nbsp;Carmel M. Hawley,&nbsp;Elaine M. Pascoe,&nbsp;Grahame J. Elder,&nbsp;Andrea Valks,&nbsp;Sunil V. Badve","doi":"10.1111/imj.16516","DOIUrl":"10.1111/imj.16516","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aims</h3>\u0000 \u0000 <p>Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) and has been associated with abnormalities of mineral metabolism and vascular calcification. Vitamin D influences parathyroid hormone values and calcium and phosphate metabolism, and may play a role in vascular function and bone health. We aimed to test our hypothesis that vitamin D deficiency is associated with arterial stiffness, aortic calcification and lower bone mineral density (BMD) in patients with CKD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A cross-sectional analysis was performed using baseline data from the IMpact of Phosphate Reduction On Vascular Endpoints in CKD (IMPROVE-CKD) study cohort. Clinical and laboratory parameters were compared between those with and without vitamin D deficiency, defined as 25-hydroxyvitamin D (25(OH)D) &lt;50 nmol/L. Univariable and multivariable linear regression analyses were performed to assess associations between serum 25(OH)D levels and pulse wave velocity (PWV), augmentation index (AIx), abdominal aortic calcification (measured by the Agatston score) and lumbar spine BMD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Baseline 25(OHD) values were available in 208 out of 278 IMPROVE-CKD study participants, with a mean value of 70.1 ± 30.7 nmol/L. Of these, 57 (27%) patients had vitamin D deficiency. Those with 25(OH)D deficiency were more likely to have diabetes (56% vs 38%), cardiovascular disease (54% vs 36%) and lower serum calcium (2.29 ± 0.13 vs 2.34 ± 0.13 mmol/L). On univariable and multivariable regression analyses, baseline 25(OH)D values were not associated with PWV, the AIx, Agatston score or BMD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Baseline 25(OH)D levels were not associated with intermediate markers of vascular function and BMD in patients with CKD stages 3b and 4.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 12","pages":"1960-1969"},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16516","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142119737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two new cases of poppy seed tea dependence: using new formulations for an old condition 两个罂粟籽茶依赖症新病例:用新配方治疗老病症
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-03 DOI: 10.1111/imj.16500
Rachit Gupta, Hae-Young C. Chong, Adam Pastor, Yvonne Bonomo
{"title":"Two new cases of poppy seed tea dependence: using new formulations for an old condition","authors":"Rachit Gupta,&nbsp;Hae-Young C. Chong,&nbsp;Adam Pastor,&nbsp;Yvonne Bonomo","doi":"10.1111/imj.16500","DOIUrl":"https://doi.org/10.1111/imj.16500","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 9","pages":"1585"},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib 用达帕替尼同时治疗普秃和溃疡性结肠炎
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-03 DOI: 10.1111/imj.16484
Tsz Hong Yiu, Elizabeth Chow, Claire Grills, Christopher F. D. Li Wai Suen
{"title":"Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib","authors":"Tsz Hong Yiu,&nbsp;Elizabeth Chow,&nbsp;Claire Grills,&nbsp;Christopher F. D. Li Wai Suen","doi":"10.1111/imj.16484","DOIUrl":"https://doi.org/10.1111/imj.16484","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 9","pages":"1583-1584"},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author reply re: Confounding factors in pregnancy outcomes among Indigenous Australian systemic lupus erythematosus patients 作者回复:澳大利亚土著系统性红斑狼疮患者妊娠结局的干扰因素。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2024-09-03 DOI: 10.1111/imj.16498
Johannes C Nossent, Charles Inderjeeth, Helen Keen
{"title":"Author reply re: Confounding factors in pregnancy outcomes among Indigenous Australian systemic lupus erythematosus patients","authors":"Johannes C Nossent,&nbsp;Charles Inderjeeth,&nbsp;Helen Keen","doi":"10.1111/imj.16498","DOIUrl":"10.1111/imj.16498","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 9","pages":"1592"},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信